In a study conducted by Mohamed et al. (7), the expression levels of serum miRNA-106a and miRNA-20a, along with inflammatory cytokines (TNF-α, IFN-γ, IL-10), and Toll-like receptor 4 (TLR4) were investigated in COVID-19 patients. The gene discussed is TLR4; the disease is COVID-19.